• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真核翻译起始因子作为癌症治疗的有希望的靶点。

Eukaryotic translation initiation factors as promising targets in cancer therapy.

机构信息

Faculty of Environmental Science and Engineering, Kunming University of Science and Technology, 727 Jingming South Road, Kunming, 650500, China.

Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, China.

出版信息

Cell Commun Signal. 2020 Nov 4;18(1):175. doi: 10.1186/s12964-020-00607-9.

DOI:10.1186/s12964-020-00607-9
PMID:33148274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7640403/
Abstract

The regulation of the translation of messenger RNA (mRNA) in eukaryotic cells is critical for gene expression, and occurs principally at the initiation phase which is mainly regulated by eukaryotic initiation factors (eIFs). eIFs are fundamental for the translation of mRNA and as such act as the primary targets of several signaling pathways to regulate gene expression. Mis-regulated mRNA expression is a common feature of tumorigenesis and the abnormal activity of eIF complexes triggered by upstream signaling pathways is detected in many tumors, leading to the selective translation of mRNA encoding proteins involved in tumorigenesis, metastasis, or resistance to anti-cancer drugs, and making eIFs a promising therapeutic target for various types of cancers. Here, we briefly outline our current understanding of the biology of eIFs, mainly focusing on the effects of several signaling pathways upon their functions and discuss their contributions to the initiation and progression of tumor growth. An overview of the progress in developing agents targeting the components of translation machinery for cancer treatment is also provided. Video abstract.

摘要

真核细胞中信使 RNA(mRNA)翻译的调控对基因表达至关重要,主要发生在起始阶段,主要受真核起始因子(eIFs)调控。eIFs 是 mRNA 翻译的基础,因此是几种信号通路调节基因表达的主要靶点。mRNA 表达失调是肿瘤发生的常见特征,上游信号通路触发的 eIF 复合物异常活性在许多肿瘤中被检测到,导致与肿瘤发生、转移或对抗癌药物耐药相关的编码蛋白质的 mRNA 选择性翻译,使 eIF 成为各种类型癌症有前途的治疗靶点。在这里,我们简要概述了我们对 eIF 生物学的现有理解,主要集中在几种信号通路对其功能的影响,并讨论了它们对肿瘤生长起始和进展的贡献。还提供了靶向翻译机制成分治疗癌症的进展概述。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/8c49e2d60598/12964_2020_607_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/ccd37c0d37c1/12964_2020_607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/51c539497e14/12964_2020_607_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/7756d95f8a72/12964_2020_607_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/c319ea484559/12964_2020_607_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/8c49e2d60598/12964_2020_607_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/ccd37c0d37c1/12964_2020_607_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/51c539497e14/12964_2020_607_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/7756d95f8a72/12964_2020_607_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/c319ea484559/12964_2020_607_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b9bb/7640403/8c49e2d60598/12964_2020_607_Fig5_HTML.jpg

相似文献

1
Eukaryotic translation initiation factors as promising targets in cancer therapy.真核翻译起始因子作为癌症治疗的有希望的靶点。
Cell Commun Signal. 2020 Nov 4;18(1):175. doi: 10.1186/s12964-020-00607-9.
2
Eukaryotic translation initiation factors and cancer.真核生物翻译起始因子与癌症
Tumour Biol. 2017 Jun;39(6):1010428317709805. doi: 10.1177/1010428317709805.
3
Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.翻译后文本:翻译失控:肿瘤发生的新机制和癌症治疗的新靶点。
Biosci Rep. 2011 Feb;31(1):1-15. doi: 10.1042/BSR20100077.
4
Eukaryotic translation initiation factors in cancer development and progression.真核翻译起始因子在癌症发生发展中的作用。
Cancer Lett. 2013 Oct 28;340(1):9-21. doi: 10.1016/j.canlet.2013.06.019. Epub 2013 Jul 2.
5
Translation initiation in cancer at a glance.癌症中的翻译起始:一目了然。
J Cell Sci. 2021 Jan 13;134(1):jcs248476. doi: 10.1242/jcs.248476.
6
Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis.异常蛋白质合成与癌症发生:经典真核起始、延伸和终止因子在肿瘤发生中的作用。
Semin Cancer Biol. 2022 Nov;86(Pt 3):151-165. doi: 10.1016/j.semcancer.2022.04.006. Epub 2022 Apr 26.
7
Dual abrogation of MNK and mTOR: a novel therapeutic approach for the treatment of aggressive cancers.MNK和mTOR的双重阻断:一种治疗侵袭性癌症的新疗法。
Future Med Chem. 2017 Sep;9(13):1539-1555. doi: 10.4155/fmc-2017-0062. Epub 2017 Aug 25.
8
eIF4B controls survival and proliferation and is regulated by proto-oncogenic signaling pathways.真核起始因子 4B(eIF4B)控制细胞的存活和增殖,并受到原癌基因信号通路的调控。
Cell Cycle. 2010 Oct 15;9(20):4106-9. doi: 10.4161/cc.9.20.13630. Epub 2010 Oct 13.
9
Molecular Pathways: The eIF4F Translation Initiation Complex-New Opportunities for Cancer Treatment.分子途径:eIF4F 翻译起始复合物——癌症治疗的新机遇。
Clin Cancer Res. 2017 Jan 1;23(1):21-25. doi: 10.1158/1078-0432.CCR-14-2362. Epub 2016 Oct 27.
10
Translation control of mRNAs encoding mammalian translation initiation factors.编码哺乳动物翻译起始因子的mRNA的翻译调控。
Gene. 2018 Apr 20;651:174-182. doi: 10.1016/j.gene.2018.02.013. Epub 2018 Feb 4.

引用本文的文献

1
Sigma-1 Receptor Activation by Fluvoxamine Ameliorates ER Stress, Synaptic Dysfunction and Behavioral Deficits in a Ketamine Model of Schizophrenia.氟伏沙明激活西格玛-1受体可改善精神分裂症氯胺酮模型中的内质网应激、突触功能障碍和行为缺陷。
J Neuroimmune Pharmacol. 2025 Jul 25;20(1):76. doi: 10.1007/s11481-025-10231-4.
2
Modulation of Endoplasmic Reticulum Stress in Experimental Anti-Cancer Therapy.实验性抗癌治疗中内质网应激的调节
Int J Mol Sci. 2025 Jul 3;26(13):6407. doi: 10.3390/ijms26136407.
3
The Role of S6K1 in Aging and Alzheimer's Disease: Mechanistic Insights and Therapeutic Potential.

本文引用的文献

1
A short translational ramp determines the efficiency of protein synthesis.短的翻译延伸决定蛋白质合成的效率。
Nat Commun. 2019 Dec 18;10(1):5774. doi: 10.1038/s41467-019-13810-1.
2
Targeting PI3K signaling in cancer: Challenges and advances.靶向癌症中的 PI3K 信号通路:挑战与进展。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):361-366. doi: 10.1016/j.bbcan.2019.03.003. Epub 2019 Apr 1.
3
Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors.PI3K 抑制剂临床开发面临的挑战:提高其在实体瘤中疗效的策略。
S6K1在衰老和阿尔茨海默病中的作用:机制洞察与治疗潜力
Int J Mol Sci. 2025 Jun 20;26(13):5923. doi: 10.3390/ijms26135923.
4
Knowledge Discovery in Databases of Proteomics by Systems Modeling in Translational Research on Pancreatic Cancer.胰腺癌转化研究中通过系统建模在蛋白质组学数据库中进行知识发现。
Proteomes. 2025 May 29;13(2):20. doi: 10.3390/proteomes13020020.
5
Aurintricarboxylic acid inhibits the malignant phenotypes of drug-resistant cells via translation regulation.金精三羧酸通过翻译调控抑制耐药细胞的恶性表型。
Front Oncol. 2025 May 14;15:1576685. doi: 10.3389/fonc.2025.1576685. eCollection 2025.
6
Emerging clinical and research approaches in targeted therapies for high-risk neuroblastoma.高危神经母细胞瘤靶向治疗中的新兴临床与研究方法。
Front Oncol. 2025 Mar 4;15:1553511. doi: 10.3389/fonc.2025.1553511. eCollection 2025.
7
Exploring MAP3K genes in gastric cancer: biomarkers, tumor microenvironment dynamics, and chemotherapy resistance.探索胃癌中的丝裂原活化蛋白激酶激酶激酶(MAP3K)基因:生物标志物、肿瘤微环境动态变化及化疗耐药性
Hereditas. 2025 Feb 3;162(1):15. doi: 10.1186/s41065-025-00364-0.
8
Quantitative profiling of human translation initiation reveals elements that potently regulate endogenous and therapeutically modified mRNAs.人类翻译起始的定量分析揭示了有效调节内源性和经治疗修饰的mRNA的元件。
Mol Cell. 2025 Jan 16;85(2):445-459.e5. doi: 10.1016/j.molcel.2024.11.030. Epub 2024 Dec 19.
9
New therapeutic approaches for fibrosis: harnessing translational regulation.纤维化的新治疗方法:利用翻译调控
Trends Mol Med. 2025 Jul;31(7):640-651. doi: 10.1016/j.molmed.2024.11.012. Epub 2024 Dec 16.
10
RSK1 and RSK2 as therapeutic targets: an up-to-date snapshot of emerging data.核糖體S6激酶1和核糖體S6激酶2作為治療靶點:新興數據的最新概述
Expert Opin Ther Targets. 2024 Dec;28(12):1047-1059. doi: 10.1080/14728222.2024.2433123. Epub 2024 Dec 4.
Cancer Discov. 2019 Apr;9(4):482-491. doi: 10.1158/2159-8290.CD-18-1175. Epub 2019 Mar 13.
4
Evidence for a role for Sestrin1 in mediating leucine-induced activation of mTORC1 in skeletal muscle.Sestrin1 在介导亮氨酸诱导的骨骼肌 mTORC1 激活中的作用的证据。
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E817-E828. doi: 10.1152/ajpendo.00522.2018. Epub 2019 Mar 5.
5
The Secret Life of Translation Initiation in Prostate Cancer.前列腺癌中翻译起始的隐秘机制
Front Genet. 2019 Jan 30;10:14. doi: 10.3389/fgene.2019.00014. eCollection 2019.
6
The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.mTOR下游调节因子(p-4EBP1)是卵巢癌中一种新的独立预后标志物。
J Obstet Gynaecol. 2019 May;39(4):522-528. doi: 10.1080/01443615.2018.1534091. Epub 2019 Feb 4.
7
Translational initiation factor eIF5 replaces eIF1 on the 40S ribosomal subunit to promote start-codon recognition.翻译起始因子 eIF5 取代 40S 核糖体亚基上的 eIF1 以促进起始密码子的识别。
Elife. 2018 Nov 30;7:e39273. doi: 10.7554/eLife.39273.
8
mTOR signalling and cellular metabolism are mutual determinants in cancer.mTOR 信号和细胞代谢在癌症中是相互决定因素。
Nat Rev Cancer. 2018 Dec;18(12):744-757. doi: 10.1038/s41568-018-0074-8.
9
Cancer-Associated Eukaryotic Translation Initiation Factor 1A Mutants Impair Rps3 and Rps10 Binding and Enhance Scanning of Cell Cycle Genes.癌症相关真核翻译起始因子 1A 突变体破坏 Rps3 和 Rps10 的结合并增强细胞周期基因的扫描。
Mol Cell Biol. 2019 Jan 16;39(3). doi: 10.1128/MCB.00441-18. Print 2019 Feb 1.
10
mRNA circularization by METTL3-eIF3h enhances translation and promotes oncogenesis.METTL3-eIF3h 通过 mRNA 环化增强翻译并促进致癌作用。
Nature. 2018 Sep;561(7724):556-560. doi: 10.1038/s41586-018-0538-8. Epub 2018 Sep 19.